Originalkatalog | Verfügbarkeit prüfen

Sabatolimab in combination with spartalizumab in patients with non-small cell lung cancer or melanoma who received prior treatment with anti-PD-1/PD-L1 therapy: a phase 2 multicent...

Lin, Chia-Chi, Curigliano, Giuseppe, Santoro, Armando, Kim, Dong-Wan, Tai, David, Hodi, F Stephen, Wilgenhof, Sofie, Doi, Toshihiko, Sabatos-Peyton, Catherine, Szpakowski, Sebastian, Chitnis, Shripad, Xyrafas, Alexandros, Gutzwiller, Sabine, Pastore, Alessandro, Mach, Nicolas
Veröffentlicht in: BMJ Open ; volume 14, issue 8, page e079132 ; ISSN 2044-6055 2044-6055;
2024

Originalkatalog | Verfügbarkeit prüfen

Phase I/Ib clinical trial of Sabatolimab, an Anti-TIM-3 Antibody, Alone and in Combination With Spartalizumab, an Anti-PD-1 Antibody, in Advanced Solid Tumors

Curigliano, Giuseppe, Gelderblom, Hans, Mach, Nicolas, Doi, Toshihiko, Tai, Wai Meng, Forde, Patrick M, Sarantopoulos, John, Bedard, Philippe L, Lin, Chia-Chi, Hodi, F Stephen, Wilgenhof, Sofie, Santoro, Armando, Sabatos-Peyton, Catherine, Longmire, Tyler A, Xyrafas, Alexandros, Sun, Haiying, Gutzwiller, Sabine, Manenti, Luigi, Naing, Aung
2021